TrialInternational immunopharmacology2021

Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial.

Atefeh Fakharian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.